NDC 0469-2760 – Veozah

Fezolinetant 45 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC0469-2760

Product details

Brand name
Veozah
Generic name
Fezolinetant
Labeler
Astellas Pharma US, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA216578
Marketed since
May 12, 2023
Listing expires
December 31, 2027
Pharmacologic class
Neurokinin 3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Veozah →

Package NDC codes (1)

Package NDCDescriptionSince
0469-2760-28 sample4 CARTON in 1 TRAY (0469-2760-28) / 1 BLISTER PACK in 1 CARTON (0469-2760-07) / 7 TABLET, FILM COATED in 1 BLISTER PACKMay 12, 2023

Other Veozah products